WO2003075851A3 - Compositions and methods for the treatment of anorectal disorders - Google Patents
Compositions and methods for the treatment of anorectal disorders Download PDFInfo
- Publication number
- WO2003075851A3 WO2003075851A3 PCT/US2003/007106 US0307106W WO03075851A3 WO 2003075851 A3 WO2003075851 A3 WO 2003075851A3 US 0307106 W US0307106 W US 0307106W WO 03075851 A3 WO03075851 A3 WO 03075851A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- adrenergic
- activators
- antagonists
- compounds
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003213787A AU2003213787A1 (en) | 2002-03-06 | 2003-03-05 | Compositions and methods for the treatment of anorectal disorders |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36269802P | 2002-03-06 | 2002-03-06 | |
US60/362,698 | 2002-03-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003075851A2 WO2003075851A2 (en) | 2003-09-18 |
WO2003075851A3 true WO2003075851A3 (en) | 2009-06-18 |
Family
ID=27805213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/007106 WO2003075851A2 (en) | 2002-03-06 | 2003-03-05 | Compositions and methods for the treatment of anorectal disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003213787A1 (en) |
WO (1) | WO2003075851A2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8865139B1 (en) | 2009-10-02 | 2014-10-21 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US9072667B2 (en) | 2009-07-29 | 2015-07-07 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US9167813B2 (en) | 2009-07-29 | 2015-10-27 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US9320705B2 (en) | 2002-10-25 | 2016-04-26 | Foamix Pharmaceuticals Ltd. | Sensation modifying topical composition foam |
US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
US9549898B2 (en) | 2007-12-07 | 2017-01-24 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
MXPA05004278A (en) | 2002-10-25 | 2005-10-05 | Foamix Ltd | Cosmetic and pharmaceutical foam. |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
US8598150B1 (en) | 2008-04-02 | 2013-12-03 | Jonathan R. Brestoff | Composition and method for affecting obesity and related conditions |
US8987245B2 (en) | 2008-04-02 | 2015-03-24 | Jonathan R. Brestoff Parker | Composition and method for affecting obesity and related conditions |
US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
PL3261645T3 (en) | 2015-02-27 | 2021-12-06 | Dechra Limited | Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
US11197848B2 (en) | 2018-06-01 | 2021-12-14 | Tavanta Therapeutics Hungary Incorporated | Topical amlodipine salts for the treatment of anorectal diseases |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000035434A2 (en) * | 1998-12-14 | 2000-06-22 | Cellegy Pharmaceuticals, Inc. | Compositions and methods for the treatment of anorectal disorders |
-
2003
- 2003-03-05 AU AU2003213787A patent/AU2003213787A1/en not_active Abandoned
- 2003-03-05 WO PCT/US2003/007106 patent/WO2003075851A2/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000035434A2 (en) * | 1998-12-14 | 2000-06-22 | Cellegy Pharmaceuticals, Inc. | Compositions and methods for the treatment of anorectal disorders |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US9320705B2 (en) | 2002-10-25 | 2016-04-26 | Foamix Pharmaceuticals Ltd. | Sensation modifying topical composition foam |
US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
US9549898B2 (en) | 2007-12-07 | 2017-01-24 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
US9072667B2 (en) | 2009-07-29 | 2015-07-07 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US9167813B2 (en) | 2009-07-29 | 2015-10-27 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
US8865139B1 (en) | 2009-10-02 | 2014-10-21 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US8992896B2 (en) | 2009-10-02 | 2015-03-31 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
Also Published As
Publication number | Publication date |
---|---|
AU2003213787A1 (en) | 2003-09-22 |
WO2003075851A2 (en) | 2003-09-18 |
AU2003213787A8 (en) | 2009-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003075851A3 (en) | Compositions and methods for the treatment of anorectal disorders | |
BR9916162A (en) | Composition and method for the treatment of an anorectal disorder and for controlling the pain associated with it | |
WO1999010338A3 (en) | Benzylidene- and cinnamylidene-anabaseines as neuronal nicotinic alpha-7 receptor agonists | |
WO2000056301A3 (en) | Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders | |
WO2004052348A3 (en) | Treatment of diseases with combinations of alpha 7 nicotinic acetylcholine receptor agonists and other compounds | |
ZA200500951B (en) | Azabicyclo derivatives as muscarinic receptor antagonists | |
BRPI0610876B8 (en) | compound, pharmaceutical formulation, and methods of inhibiting an activity of a jak kinase, and of inhibiting a signal transduction cascade in which jak3 kinase plays a role | |
PL409305A1 (en) | 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile and the pharmaceutical composition and their use | |
EP1369129A4 (en) | Remedies for depression containing ep1 antagonist as the active ingredient | |
YU33802A (en) | Polycycloalkylpurines as adenosine receptor antagonists | |
EP1990338A3 (en) | Biphenylcyclopropylamides as p-38 Kinase inhibitors | |
WO2006068826A3 (en) | 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors | |
HK1077193A1 (en) | Alpha-7 nicotinic receptor agonists and statins incombination | |
MY145332A (en) | Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors | |
MXPA06010904A (en) | Tricyclic pyrazole kinase inhibitors. | |
WO2007044441A3 (en) | Use of pyrazolo [1 , 5 -a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases | |
HK1064948A1 (en) | Use of an adenosine a3 receptor agonist for inhibition of viral replication | |
WO2006060127A3 (en) | COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE | |
IL174762A0 (en) | Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angiotensin ii receptor blocker | |
MXPA03003482A (en) | Treatment of sexual dysfunction. | |
WO2004103288A3 (en) | Method of preventing recurrent miscarriages | |
WO2004041755A3 (en) | Quinazolinone compounds as calcilytics | |
YU33702A (en) | Adenosine receptor antagonists and methods of making and using the same | |
CR20230306A (en) | Novel compounds as androgen receptor and phosphodiesterase dual inhibitor | |
WO2001078653A3 (en) | Graft rejection inhibition with ccr2 inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |